Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.

Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.

Item
http://www.wikidata.org/entity/Q34478450
KPU-300, a Novel Benzophenone-Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M PhaseIdentification of a characteristic vascular belt zone in human colorectal cancerMagnetic Resonance Imaging (MRI) of Intratumoral Voxel Heterogeneity as a Potential Response Biomarker: Assessment in a HER2+ Esophageal Adenocarcinoma Xenograft Following Trastuzumab and/or Cisplatin Therapy.In vivo spectral and fluorescence microscopy comparison of microvascular function after treatment with OXi4503, Sunitinib and their combination in Caki-2 tumors.Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis.Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine ModelTreatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents.Prevention of cancer recurrence in tumor margins by stopping microcirculation in the tumor and tumor-host interfaceThe prognostic significance of lymphatics in colorectal liver metastasesStarvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.Spatiotemporal heterogeneity of tumor vasculature during tumor growth and antiangiogenic treatment: MRI assessment using permeability and blood volume parameters.
P2860

Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.

Item
http://www.wikidata.org/entity/Q34478450
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Spatial morphological and mole ...... r disruptive agent treatments.
@ast
Spatial morphological and mole ...... r disruptive agent treatments.
@en
Spatial morphological and mole ...... r disruptive agent treatments.
@nl
type
label
Spatial morphological and mole ...... r disruptive agent treatments.
@ast
Spatial morphological and mole ...... r disruptive agent treatments.
@en
Spatial morphological and mole ...... r disruptive agent treatments.
@nl
prefLabel
Spatial morphological and mole ...... r disruptive agent treatments.
@ast
Spatial morphological and mole ...... r disruptive agent treatments.
@en
Spatial morphological and mole ...... r disruptive agent treatments.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Spatial morphological and mole ...... ar disruptive agent treatments
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P5875
P6179
P698
P932